DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

51.84 -0.11 (-0.21%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $51.84 -0.21%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $52.01
Previous Close $51.95
Daily Range $51.67 - $52.31
52-Week Range $46.30 - $57.49
Market Cap $85.9B
P/E Ratio 32.27
Dividend (Yield) $1.44 (2.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,227,150
Average Daily Volume 6,047,995
Current FY EPS $1.76





Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

Is It Time to Buy Eli Lilly & Co.'s Stock?

Eli Lilly & Co. is promising big things, but has optimism in the stock gotten ahead of reality? It's time to ask if now's the right time to invest.

Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog

Bristol-Myers Squibb Earnings Preview: What We Are Watching

3 Stocks Reiterated As A Buy: BMY, BIDU, QCOM

Gilead Sciences: Pricing, Politics And Profits

Market Reaction To Johnson & Johnson's Earnings Is Justified

3 Drugs Stocks Dragging The Industry Down

What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock

Slipping sales for Johnson & Johnson's hepatitis C drug Olysio may give Gilead investors reason for pause.

Weekly CFO Sells Highlight: Williams Companies Inc, Google Inc, Bristol-Myers Squibb Company

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

See More BMY News...

BMY's Top Competitors

BMY $51.84 (-0.21%)
Current stock: BMY
JNJ $101.22 (0.86%)
Current stock: JNJ
NVS $88.20 (-0.46%)
Current stock: NVS
RHHBY $36.36 (-0.10%)
Current stock: RHHBY